CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
Conditions: ACS - Acute Coronary Syndrome; CYP2C19 Polymorphism Interventions: Drug: CYP2C19 Genotype Guided DAPT; Drug: Conventional DAPT Sponsors: Zunyi Medical College Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Drug-Coated Balloon in Native Chronic Total Occlusion Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease; Total Occlusion of Coronary Artery Interventions: Device: Paclitaxel Drug-coated balloon Sponsors: National Institute of Cardiology, Warsaw, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention
Conditions: ECMO; High-risk PCI Interventions: Procedure: Standby cannulated ECMO; Procedure: Prophylactic ECMO Sponsors: Beijing Anzhen Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
Drug-coated Balloon Treatment in Coronary Lesions
Conditions: Drug-coated Balloon Interventions: Device: Angioplasty Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 19, 2024 Category: Research Source Type: clinical trials
Left Main Percutaneous Coronary Intervention Registry in Istanbul Medipol University Hospital
Conditions: Coronary Artery Disease; Left Main Coronary Artery Disease Interventions: Device: Percutaneous coronary intervention Sponsors: Medipol University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Bail-Out Stenting and Target-vessel Failure After Drug Coated Balloon Coronary percutaneouS Angioplasty for de Novo Lesions
Conditions: DCB; De Novo Stenosis; PCI Sponsors: IRCCS Azienda Ospedaliero-Universitaria di Bologna Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease Interventions: Drug: Ticagrelor 60mg; Drug: Clopidogrel Sponsors: University of Florida; Scott R. MacKenzie Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2024 Category: Research Source Type: clinical trials
Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.
Conditions: Coronary Artery Disease Interventions: Device: VIVO ISAR DES implanted in the First lesion, XIENCE Skypoint DES implanted in the Second lesion; Device: XIENCE Skypoint DES implanted in the First lesion, VIVO ISAR DES implanted in the Second lesion Sponsors: Fundaci ón EPIC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
The 5th Generation Tele-Robotic-Assisted Percutaneous Coronary Intervention: A First-in-Human Trial
Conditions: Coronary Artery Disease; Myocardial Ischemia; Cardiovascular Diseases; Coronary Disease; Arteriosclerosis Interventions: Device: 5G Tele-Robotic-Assisted PCI Sponsors: Yan ' an Affiliated Hospital of Kunming Medical University; Shanghai Zhongshan Hospital; Kunming Chenggong District People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison
Conditions: Chronic Thromboembolic Pulmonary Hypertension Interventions: Procedure: Balloon Pulmonary Angioplasty combined with Pulmonary Artery Denervation; Procedure: Balloon Pulmonary Angioplasty with Sham Pulmonary Artery Denervation Sponsors: Boris Dzudovic; Military Medical Academy, Belgrade, Serbia; Galen Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
Conditions: Coronary Artery Disease Interventions: Device: Mozec ™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter Sponsors: University National Heart Hospital; Meril Life Sciences Pvt. Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Conditions: Coronary Artery Disease; Dyslipidemias; Primary Prevention Interventions: Drug: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg; Drug: Mono drug group of Rosuvastatin 20 mg Sponsors: Saint Vincent ' s Hospital, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2023 Category: Research Source Type: clinical trials
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Conditions: Arterial Disease of Legs Interventions: Device: MagicTouch PTA Sirolimus drug coated balloon; Device: Placebo balloon angioplasty Sponsors: Concept Medical Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials
Assessment of Cutting-Balloon Angioplasty With EES in the Treatment of CCL Guided by IVUS
Conditions: Coronary Artery Disease Interventions: Device: Wolverine cutting balloon; Device: Non-compliant balloon Sponsors: Soonchunhyang University Hospital; Boston Scientific Corporation; Eulji University; The Catholic University of Korea; Hanil General Hospital, Korea Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
Assessment of Cutting-Balloon Angioplasty With Everolimus-Eluting Stent(EES) in the Treatment of Coronary Calcified Lesion(CCL) Guided by Intravascular Ultrasonography(IVUS)
Conditions: Coronary Artery Disease Interventions: Device: Wolverine cutting balloon; Device: Non-compliant balloon Sponsors: Soonchunhyang University Hospital; Boston Scientific Corporation; Eulji University; The Catholic University of Korea; Hanil General Hospital, Korea Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
